Digital Health Interventions Are Effective for Irritable Bowel Syndrome Self-Management: A Systematic Review
- PMID: 39402208
- PMCID: PMC11839690
- DOI: 10.1007/s10620-024-08672-7
Digital Health Interventions Are Effective for Irritable Bowel Syndrome Self-Management: A Systematic Review
Abstract
Background: Digital health interventions (DHIs) could be a valuable self-management tool for patients with irritable bowel syndrome (IBS), but little research exists on IBS-focused DHIs and their effectiveness. This review aimed to identify DHIs for IBS and evaluate their characteristics, effectiveness, and feasibility.
Methods: Our study team, including patient partners, conducted a systematic review using Medline, PsycINFO, Embase, Web of Science, and CINAHL from database inception to May 2024. Experimental and observational studies evaluating DHIs designed for use by IBS patients were included. Data extraction and assessment included study and DHI characteristics, effectiveness outcomes (symptom severity, quality of life, psychological indices, patient empowerment), and feasibility measures (adherence, usability, user satisfaction). Study quality and bias were assessed using a modified checklist of Downs and Black.
Results: Of the 929 identified, 13 studies of DHIs were included and deemed good quality on average (21,510 total participants) with six primary areas of focus: education, diet, brain-gut behavior skills, physiological support, health monitoring, and community engagement. Most DHIs were self-directed and reported statistically significant improvements in most effectiveness outcomes. Evidence suggests that DHIs focusing on brain-gut behavior skills or health monitoring may be most effective compared to other types of DHIs. However, their feasibility remains unclear, and the generalization of their impacts is limited.
Conclusion: This review underscores the potential of DHIs in supporting IBS patients and improving their outcomes. However, additional research is warranted for continued intervention use in this population, including assessments on feasibility, safety, cost-effectiveness, and patient empowerment and experiences.
Keywords: Digital health; Effectiveness; Feasibility; Irritable bowel syndrome; Self-management; Systematic review.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: DAM reports personal fees from the Office of Health Economics, Astellas, and Novartis and meeting expenses from Illumina. AD, MVM, JS, and NH disclose no conflicts of interest.
Figures
Similar articles
-
The Cost-Effectiveness of Digital Health Interventions on the Management of Cardiovascular Diseases: Systematic Review.J Med Internet Res. 2019 Jun 17;21(6):e13166. doi: 10.2196/13166. J Med Internet Res. 2019. PMID: 31210136 Free PMC article.
-
Personalization in digital health interventions for older adults with cancer: A scoping review.J Geriatr Oncol. 2023 Nov;14(8):101652. doi: 10.1016/j.jgo.2023.101652. Epub 2023 Oct 21. J Geriatr Oncol. 2023. PMID: 37866009
-
Efficacy of a Digital Personalized Elimination Diet for the Self-Management of Irritable Bowel Syndrome and Comorbid Irritable Bowel Syndrome and Inflammatory Bowel Disease.Clin Transl Gastroenterol. 2023 Jan 1;14(1):e00545. doi: 10.14309/ctg.0000000000000545. Clin Transl Gastroenterol. 2023. PMID: 36322404 Free PMC article.
-
Homeopathy for treatment of irritable bowel syndrome.Cochrane Database Syst Rev. 2019 Sep 4;9(9):CD009710. doi: 10.1002/14651858.CD009710.pub3. Cochrane Database Syst Rev. 2019. PMID: 31483486 Free PMC article.
-
Pain self-management plus nurse-led support in young adults with irritable bowel syndrome: Study protocol for a pilot randomized control trial.Res Nurs Health. 2018 Apr;41(2):121-130. doi: 10.1002/nur.21862. Epub 2018 Feb 1. Res Nurs Health. 2018. PMID: 29388674 Free PMC article. Clinical Trial.
Cited by
-
Digital Health Interventions for IBS: Ready for Prime Time?Dig Dis Sci. 2025 Feb;70(2):454-455. doi: 10.1007/s10620-024-08804-z. Epub 2024 Dec 21. Dig Dis Sci. 2025. PMID: 39708262 No abstract available.
References
-
- Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020;17:473–486. - PubMed
-
- Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;510:908–917. - PubMed
-
- Lacy BE, Pimentel M, Brenner DM et al. ACG clinical guideline: Management of irritable bowel syndrome. Off J Am Coll Gastroenterol ACG. 2021;1161:17–44. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources